カテゴリー： QYResearch, 世界

基底細胞がん治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書（QY21APR0706）
◆英語タイトル：Global Basal Cell Carcinoma Therapeutics Market Size, Status and Forecast 2021-2027
◆商品コード：QY21APR0706
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2021年4月
◆ページ数：90
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥499,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥748,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
本調査資料では、基底細胞がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線療法、光線力学療法、薬剤）、用途別市場規模（小売薬局、病院薬局、がん研究機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・基底細胞がん治療の市場動向
・企業の競争状況、市場シェア
・基底細胞がん治療の種類別市場規模（手術、放射線療法、光線力学療法、薬剤）
・基底細胞がん治療の用途別市場規模（小売薬局、病院薬局、がん研究機関）
・基底細胞がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・基底細胞がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・基底細胞がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・基底細胞がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・基底細胞がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sun Pharmaceuticals、Bausch Health、Mylan、F. Hoffmann-La Roche、Merck）
・結論
【レポートの概要】

Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening by metastasis only in extremely rare cases. According to the American Cancer Society, BCCs constitute around 80% of all non-melanoma skin cancers. Australia has been found to have the highest rate of basal cell carcinoma across the globe. Exposure to ultraviolet radiation is considered as the major cause behind BCC. Use of immunosuppressant drugs further enhance the chances of BCC as the immune system is compromised. White people are more vulnerable to BCC comparatively, according to a research published in the British Medical Journal. The symptoms of BCCs include waxy papules (slightly transparent bump) with pearly appearance and central depression and bleeding from the papules.
The increase in geriatric population, giving rise to numerous skin diseases, such as actinic keratosis and other non-melanoma skin malignancies, is another important factor that has been fueling the demand for basal cell carcinoma treatment substantially. In addition to these, the market is expected to gain considerably from the changing lifestyle of people in developing economies over the coming years as it is anticipated to drive demand for better disease treatments, which in turn, is likely to provide lucrative opportunities for the companies operating in the global basal cell carcinoma treatment market.

Market Analysis and Insights: Global Basal Cell Carcinoma Therapeutics Market
The global Basal Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Basal Cell Carcinoma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Basal Cell Carcinoma Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Basal Cell Carcinoma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Basal Cell Carcinoma Therapeutics market.

Global Basal Cell Carcinoma Therapeutics Scope and Market Size
Basal Cell Carcinoma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Basal Cell Carcinoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Radiation Therapy
Photodynamic Therapy
Drugs

Segment by Application
Retail Pharmacies
Hospitals Pharmacies
Cancer Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sun Pharmaceuticals
Bausch Health
Mylan
F. Hoffmann-La Roche
Merck

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Basal Cell Carcinoma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Radiation Therapy
1.2.4 Photodynamic Therapy
1.2.5 Drugs
1.3 Market by Application
1.3.1 Global Basal Cell Carcinoma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacies
1.3.3 Hospitals Pharmacies
1.3.4 Cancer Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Basal Cell Carcinoma Therapeutics Market Perspective (2016-2027)
2.2 Basal Cell Carcinoma Therapeutics Growth Trends by Regions
2.2.1 Basal Cell Carcinoma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Basal Cell Carcinoma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Basal Cell Carcinoma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Basal Cell Carcinoma Therapeutics Industry Dynamic
2.3.1 Basal Cell Carcinoma Therapeutics Market Trends
2.3.2 Basal Cell Carcinoma Therapeutics Market Drivers
2.3.3 Basal Cell Carcinoma Therapeutics Market Challenges
2.3.4 Basal Cell Carcinoma Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Basal Cell Carcinoma Therapeutics Players by Revenue
3.1.1 Global Top Basal Cell Carcinoma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Basal Cell Carcinoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Basal Cell Carcinoma Therapeutics Revenue
3.4 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio
3.4.1 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Basal Cell Carcinoma Therapeutics Revenue in 2020
3.5 Basal Cell Carcinoma Therapeutics Key Players Head office and Area Served
3.6 Key Players Basal Cell Carcinoma Therapeutics Product Solution and Service
3.7 Date of Enter into Basal Cell Carcinoma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Basal Cell Carcinoma Therapeutics Breakdown Data by Type
4.1 Global Basal Cell Carcinoma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Type (2022-2027)

5 Basal Cell Carcinoma Therapeutics Breakdown Data by Application
5.1 Global Basal Cell Carcinoma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Basal Cell Carcinoma Therapeutics Market Size (2016-2027)
6.2 North America Basal Cell Carcinoma Therapeutics Market Size by Type
6.2.1 North America Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
6.3 North America Basal Cell Carcinoma Therapeutics Market Size by Application
6.3.1 North America Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
6.4 North America Basal Cell Carcinoma Therapeutics Market Size by Country
6.4.1 North America Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Basal Cell Carcinoma Therapeutics Market Size (2016-2027)
7.2 Europe Basal Cell Carcinoma Therapeutics Market Size by Type
7.2.1 Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Basal Cell Carcinoma Therapeutics Market Size by Application
7.3.1 Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Basal Cell Carcinoma Therapeutics Market Size by Country
7.4.1 Europe Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Basal Cell Carcinoma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Basal Cell Carcinoma Therapeutics Market Size (2016-2027)
9.2 Latin America Basal Cell Carcinoma Therapeutics Market Size by Type
9.2.1 Latin America Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Basal Cell Carcinoma Therapeutics Market Size by Application
9.3.1 Latin America Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Basal Cell Carcinoma Therapeutics Market Size by Country
9.4.1 Latin America Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Basal Cell Carcinoma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sun Pharmaceuticals
11.1.1 Sun Pharmaceuticals Company Details
11.1.2 Sun Pharmaceuticals Business Overview
11.1.3 Sun Pharmaceuticals Basal Cell Carcinoma Therapeutics Introduction
11.1.4 Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021)
11.1.5 Sun Pharmaceuticals Recent Development
11.2 Bausch Health
11.2.1 Bausch Health Company Details
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Basal Cell Carcinoma Therapeutics Introduction
11.2.4 Bausch Health Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021)
11.2.5 Bausch Health Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Basal Cell Carcinoma Therapeutics Introduction
11.3.4 Mylan Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Basal Cell Carcinoma Therapeutics Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Basal Cell Carcinoma Therapeutics Introduction
11.5.4 Merck Revenue in Basal Cell Carcinoma Therapeutics Business (2016-2021)
11.5.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 基底細胞がん治療の世界市場規模・現状・予測2021年-2027年(Global Basal Cell Carcinoma Therapeutics Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 進行腎細胞がん治療の世界市場規模・現状・予測2021年-2027年 Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell carcinoma is the most common type of kidney cancer in adults that represents nearly 2-3% of all cancer cases in adults. The disorder is asymptomatic in advanced renal cell carcinoma at initial stages that results with people often in the advanced stages of the disease by the time it...
  • 皮膚がん診断＆治療の世界市場規模・現状・予測2021年-2027年 On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth. In 2017, North America was the largest regional market, in terms of revenue. The high prevalence of skin cancer and its risk...
  • 進行腎細胞がん治療の世界市場規模・現状・予測2021年-2027年 Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell carcinoma is the most common type of kidney cancer in adults that represents nearly 2-3% of all cancer cases in adults. The disorder is asymptomatic in advanced renal cell carcinoma at initial stages that results with people often in the advanced stages of the disease by the time it...
  • 皮膚がん診断＆治療の世界市場規模・現状・予測2021年-2027年 On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth. In 2017, North America was the largest regional market, in terms of revenue. The high prevalence of skin cancer and its risk...
  • 基底細胞がん治療の世界市場規模・現状・予測2021年-2027年 Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening by metastasis only in extremely rare cases. According to the American Cancer Society, BCCs constitute around 80% of all non-melanoma skin cancers. Australia has been found to have the highest rate of basal cell carcinoma across the globe. Exposure to ultraviolet radiation is considered as the major cause...
  • メルケル細胞癌治療の世界市場規模・現状・予測2021年-2027年 Merkel Cell Carcinoma, a skin malignancy, is caused by the uncontrolled development of Merkel cells in the skin. MCC was originally first described by Toker in 1972. The malady is to a great extent caused by Merkel Cell Polyomavirus (MCV) on parts of the skin in the head, neck and arms, generally occurs most often on sun-exposed areas of the skin.  Market Analysis and Insights: Global Merkel Cell Carcinoma Treatment Market The global Merkel Cell Carcinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy...
  • 基底細胞皮膚がん治療の世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Basal Cell Skin Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global...
  • 基底細胞がん治療の世界市場規模・現状・予測2021年-2027年 Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC. Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams or ointments. Surgical options are Electrodesiccation and curettage (ED&C), Topical Treatment, Freezing and Mohs Surgery. Drugs options, imiquimod (Aldara) and fluorouracil (Efudex, Fluoroplex, others) are used for several weeks to treat such low-risk basal cell carcinomas. Basal cell carcinoma that spreads to other areas of the body (metastasizes)...
  • 副腎皮質がん治療の世界市場規模・現状・予測2021年-2027年 Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer is what happens when another form of cancer spreads to the adrenal glands. Adrenocortical carcinoma can occur at any age, but there is a bimodal distribution with a first peak...
  • 頭頸部扁平上皮がん（HNSCC）治療の世界市場規模・現状・予測2021年-2027年 Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global Squamous Cell Carcinoma of the Head and Neck Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key...
  • 頭頸部扁平上皮がん治療の世界市場規模・現状・予測2021年-2027年 Head and neck squamous cell carcinoma is the sixth leading cancer worldwide by incidence. Head and neck squamous cell carcinoma progresses from the mucosal membrane, comprising the paranasal sinuses and nasal cavity, the nasopharynx, the hypopharynx, larynx, and trachea, and the oropharynx and oral cavity. According to WHO, The annual incidence of head and neck squamous cell carcinoma worldwide is more than 550,000 cases with around 300,000 deaths every year. Alcohol and tobacco is the risk factor for head and neck squamous cell carcinoma. Five years survival rate of patients with head and neck squamous cell carcinoma is about 40-50%....
  • メルケル細胞癌治療の世界市場規模・現状・予測2021年-2027年 Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. Market Analysis and Insights: Global Merkel Cell Carcinoma Therapeutics Market The global Merkel Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Merkel Cell Carcinoma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including...
  • 結腸・直腸がんの世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global Colon & Rectal Carcinoma Market The global Colon & Rectal Carcinoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colon & Rectal Carcinoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colon & Rectal...
  • 移行細胞がん治療薬の世界市場規模・現状・予測2021年-2027年 Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra. Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking. Market Analysis and Insights: Global Transitional Cell Cancer Therapeutics Market The global Transitional Cell Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities...
  • 有毛細胞白血病治療の世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global Hairy Cell Leukemia Therapeutics Market The global Hairy Cell Leukemia Therapeutics market size is projected to reach US$ 119.1 million by 2026, from US$ 86 million in 2019, at a CAGR of 4.8% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hairy Cell Leukemia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hairy Cell Leukemia...